by Instem Team | Mar 15, 2026 | Resources
Vivarium managers and research staff face increasing pressure to maintain well‑organized, compliant, and high‑integrity colony data while supporting fast‑paced research timelines. Legacy spreadsheets and disconnected tools make it difficult to track breeding programs,...
by Instem Team | Mar 12, 2026 | Clinical
Across the life sciences sector, pressure on R&D productivity and profitability is intensifying. Pricing constraints, patent expirations, and organizational restructuring are forcing pharmaceutical and biotech companies to do more with fewer resources. At the same...
by Instem Team | Mar 11, 2026 | In Silico & Data Insights, Regulatory Submission, Study Management
Discovery Given that a single high-throughput screening campaign may evaluate over 2 million compounds, discovery teams must move through terabytes of data before deciding to prioritize only a handful of compounds after target identification. When data and rationale...
by Instem Team | Mar 6, 2026 | Clinical, Resources
Open-source software has been increasingly popular in biostatistics and life sciences. While SAS has been the go-to programming language for biostatistics, R and other open-source languages are being utilized more often. R, known for its distinct capabilities and...
by Instem Team | Mar 4, 2026 | In Silico & Data Insights, Regulatory Submission, Study Management
The earliest stages of drug research and development (R&D) generate massive volumes of scientific, operational, and compliance-critical data, often across disconnected tools, teams, and formats. That fragmentation slows decision-making, increases rework, and...
